Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.
about
The risks of overlooking the diagnosis of secreting pituitary adenomasGrowth hormone and reproduction: a review of endocrine and autocrine/paracrine interactionsDiabetes in Patients With Acromegaly.Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.Geographical information system (GIS) as a new tool to evaluate epidemiology based on spatial analysis and clinical outcomes in acromegaly.Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factorAugmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell LinePrevalence of diabetes mellitus in patients with acromegaly.The changing face of acromegaly--advances in diagnosis and treatment.Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas.Diagnosis of acromegaly: state of the art.A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.The chronic syndromes after previous treatment of pituitary tumours.Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.MTHFR C677T polymorphism, folate status and colon cancer risk in acromegalic patients.Emerging trends in the diagnosis and treatment of acromegaly in Canada.Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA).Coexistence of GH-Producing Pituitary Macroadenoma and Meningioma in a Patient with Multiple Endocrine Neoplasia Type 1 with Hyperglycemia and Ketosis as First Clinical Sign.Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients.Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly.Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide.Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.Increased Risk of Persistent Glucose Disorders After Control of Acromegaly.Time spent with cats is never wasted: Lessons learned from feline acromegalic cardiomyopathy, a naturally occurring animal model of the human disease.
P2860
Q28076665-7595B430-45FE-4B22-94D8-9E1EEA16F598Q28082801-E42D8E54-EB8A-4CC9-BED8-A7EC7BB7855BQ30238646-CB51BF81-DA04-47EE-9779-442AD299FDDEQ31139308-01FEB6C9-1D03-4278-9DF8-5E4E2A54475DQ34979883-D4DFB8AE-02CB-4A97-908B-ABC2A10B171EQ35935026-829E02ED-3B0C-434C-A37F-729849D16868Q36153987-EB783BC4-BBAF-49A4-8323-6D1D1789B609Q37669028-98B1FC57-ED05-4548-84DF-67416343630AQ38021680-C2C9D8B9-211C-43D8-8C82-C3F00A0C6721Q38060718-CF58D93E-1BCC-4E6C-8DB4-37752D3EC456Q38131055-6ACB4EB4-10D6-43C3-95CF-F46F0B164865Q38373377-167D0295-8DB6-4213-ACB4-1EADDC51A218Q38640384-69DA8C1A-2D2C-4776-8EFC-168C50E16EA9Q38683309-6C773949-6EA5-4720-A8BE-BF9843BD8A22Q38853092-D077C087-7934-40E4-A0C0-54C56F6B88D6Q39146196-37089758-8E47-4208-840B-D5E620D603AFQ43854943-E51B4BDE-1DC0-4BED-B037-B9B07CA5CA48Q44658146-4A2844B4-4E69-4DF0-AD52-6112552E563BQ47936712-1525E07C-545E-481B-9325-2D68D6CF53DAQ48145845-42E85BDF-BAAB-49C0-A6D7-03391D12DFCAQ51344066-8EC3379B-357A-4F8E-A78F-B6A86060403BQ51357274-D6B3D532-4B4F-4BFF-ABED-40564DFDE8D6Q51365761-C4C1A535-401B-45BF-83D8-57C33D7BAE86Q55293690-AA07DAA0-D344-4D84-BEBE-4AC2670087FAQ55381247-2B82DDDA-2E61-4010-9936-07F53161B929Q55396559-1BEEB35B-C2C3-493B-86B2-4E1D96A00745
P2860
Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Diabetes in acromegaly, preval ...... he French Acromegaly Registry.
@ast
Diabetes in acromegaly, preval ...... he French Acromegaly Registry.
@en
type
label
Diabetes in acromegaly, preval ...... he French Acromegaly Registry.
@ast
Diabetes in acromegaly, preval ...... he French Acromegaly Registry.
@en
prefLabel
Diabetes in acromegaly, preval ...... he French Acromegaly Registry.
@ast
Diabetes in acromegaly, preval ...... he French Acromegaly Registry.
@en
P2093
P50
P356
P1476
Diabetes in acromegaly, preval ...... the French Acromegaly Registry
@en
P2093
Brigitte Delemer
Christine Cortet
French Acromegaly Registry
Isabelle Morange
Patrick Petrossians
Sandrine Fieffe
Vincent Rohmer
P304
P356
10.1530/EJE-10-1050
P577
2011-04-04T00:00:00Z